SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-298670
Filing Date
2019-11-22
Accepted
2019-11-22 17:01:10
Documents
14
Period of Report
2019-11-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837319d8k.htm   iXBRL 8-K 27253
2 EX-99.1 d837319dex991.htm EX-99.1 38857
6 GRAPHIC g837319img01.jpg GRAPHIC 7458
  Complete submission text file 0001193125-19-298670.txt   206440

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20191122.xsd EX-101.SCH 3050
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20191122_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20191122_pre.xml EX-101.PRE 10940
9 EXTRACTED XBRL INSTANCE DOCUMENT d837319d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 191242383
SIC: 2834 Pharmaceutical Preparations